Guidelines for treatment of atopic dermatitis

Autor: Suzana Ljubojević Hadžavdić, Nives Pustišek, Liborija Lugović Mihić, Suzana Ožanić Bulić, Neira Puizina-Ivić, Sandra Peternel, Melita Vukšić Polić, Sandra Marinović Kulišić, Ružica Jurakić Tončić, Slobodna Murat-Sušić, Karmela Husar, Mihael Skerlev, Ivana Martinac Ciglar,, Tomislav Duvančić, Vedrana Bulat, Iva Dediol, Ranka Ivanišević, Iva Bojčić, Ines Brajac, Igor Kuric, Lena Kotrulja, Lucija Tomić Babić, Gordana Krnjević-Pezić, Vlatka Čavka, Andrija Stanimirović, Zrinka Bukvić Mokos, Mirna Šitum, Branka Marinović

Publikováno v: Liječnički vjesnik, Vol 144, Iss 9-10, Pp 1-10 (2022)

Atopic dermatitis is a common, chronically recurrent inflammatory skin disease characterized by a complex etiopathogenesis and a variable clinical phenotype. The clinical presentation is heterogeneous, and the disease is characterized by a recurrent

Externí odkaz: https://doaj.org/article/46d4f2f72ae84ef58ad38a267831c452

The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial)

Autor: Aviël Ragamin, Karin B. Fieten, Ron A. Tupker, Jill de Wit, Minke M. F. van Mierlo, Marieke S. Jansen, Madelon B. Bronner, Renske Schappin, Frank H. J. Schuren, Margreet L. E. Romeijn, Bernd W. M. Arents, Suzanne Polinder, Marlies de Graaf, Thomas Rustemeyer, Marie L. A. Schuttelaar, Suzanne G. M. A. Pasmans

Publikováno v: Trials
TRIALS, 22(1):902. BMC
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Trials, 22(1):902. BioMed Central Ltd.

Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10 to 20% of children and between 2 and 15% of the adults in Western Europe. Since 2000, therapeutic clothing or functional textiles based on silver or chitosan as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2476171f9da9717e89256f16c54acb
https://doi.org/10.1186/s13063-021-05836-y

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

Autor: Marijke Kamsteeg, Lotte S. Spekhorst, Marjolein S. de Bruin-Weller, Jorien van der Schaft, Lieneke F.M. Ariëns, Daphne S. Bakker, Marie L A Schuttelaar, Judith L. Thijs, Inge Haeck, Annebeth E. Flinterman

Publikováno v: Acta Dermato-Venereologica, 101
Acta dermato-venereologica, 101(10). ACTA DERMATO-VENEREOLOGICA
Acta Dermato-Venereologica, Vol 101, Iss 10 (2021)

Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa497dbe6e193a5fa4c5f001f7686082
https://doi.org/10.2340/00015555-3886

Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood: A Danish Register-based Study

Autor: Dennis J Trangbaek, Mikkel H Pedersen, Christian Vestergaard, Jacob P. Thyssen, Maria E Madsen, Andreas W Brenneche

Publikováno v: Thyssen, J P, Brenneche, A W, Madsen, M E, Pedersen, M H, Trangbaek, D J & Vestergaard, C 2021, ' Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood : A Danish Register-based Study ', Acta Dermato-Venereologica, vol. 101, no. 9, pp. adv00538 . https://doi.org/10.2340/00015555-3908
Acta Dermato-Venereologica, Vol 101, Iss 9, p adv00538 (2021)

To estimate the cost of illness in adult patients with moderate-to-severe atopic dermatitis (AD) a cohort study was conducted identifying Danish citizens (≥ 18 years) diagnosed with AD between 1997 and 2018 in the Danish National Patient Register.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5468e0f83b91f62e0666e6a10842ee9
https://pubmed.ncbi.nlm.nih.gov/34458924

Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis

Autor: Robert Kantor, Sherief R. Janmohamed, Derek Y. Hsu, Vivek Singam, Rajeev Chavda, Paras P Vakharia, Jonathan I. Silverberg, Kevin R. Patel, Sylvie Gabriel, Muhammad Yousaf, Rishi Chopra, Donald Lei

Publikováno v: J Eur Acad Dermatol Venereol

BACKGROUND: Multiple clinician-reported outcome measures exist for atopic dermatitis (AD) severity. However, there is no gold standard for use in clinical practice. OBJECTIVES: To determine the measurement properties of the product of validated Inves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdae9aabb2f06e74575ede33d7356e3d
https://hdl.handle.net/20.500.14017/2c0a446e-d7a3-495e-b20e-ff9b2deb0761